Use of mathematical modeling to inform chlamydia screening policy decisions

Journal of Infectious Diseases

Volumn 199, Issue 5, 2009, Pages 767-768

  Low, Nicola ^a   Heijne, Janneke C M ^a   Kretzschmar, Mirjam ^b,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DISEASE TRANSMISSION; HEALTH CARE POLICY; HUMAN; INFERTILITY; LETTER; MATHEMATICAL MODEL; PREVALENCE; PRIORITY JOURNAL; REINFECTION; SCREENING; SEXUAL BEHAVIOR;

ADOLESCENT; AUSTRALIA; CHLAMYDIA INFECTIONS; FEMALE; HUMANS; MASS SCREENING; MODELS, BIOLOGICAL; YOUNG ADULT;

EID: 61849100950     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/596744     Document Type: Letter

References (8)

1. Regan DG, Wilson DP, Hocking JS. Coverage is the key for effective screening of Chlamydia trachomatis in Australia. J Infect Dis 2008; 198:349-58.
2. Low N. Screening programmes for chlamydial infection: when will we ever learn? BMJ 2007; 334:725-8.
3. Scott LaMontagne D, Baster K, Emmett L, et al. Incidence and reinfection rates of genital chlamydial infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex Transm Infect 2007; 83:292-303.
4. Kretzschmar M, Welte R, van Den HA, Postma MJ. Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. Am J Epidemiol 2001; 153:90-101.
5. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med 1996; 125:605-13.
6. de VR, Van Bergen JE, de Jong-van den Berg LT, Postma MJ. Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data. PILOT-CT Study Group. Value Health 2006; 9:1-11.
7. Low N, McCarthy A, Macleod J, et al. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess 2007; 11:1-165.
8. Welte R, Kretzschmar M, Leidl R, van Den HA, Jager JC, Postma MJ. Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. Sex Transm Dis 2000; 27:518-29.